{"id":5224,"date":"2025-03-10T14:24:16","date_gmt":"2025-03-10T19:24:16","guid":{"rendered":"https:\/\/scrconsultings.com\/?p=5224"},"modified":"2026-01-27T13:23:56","modified_gmt":"2026-01-27T18:23:56","slug":"pharmacovigilance-outsourcing-peru","status":"publish","type":"post","link":"https:\/\/scrconsultings.com\/es\/pharmacovigilance-outsourcing-peru\/","title":{"rendered":"Aspectos a considerar en la Tercerizaci\u00f3n de Servicios de Farmacovigilancia"},"content":{"rendered":"<p><b><i>Q.F. Milagros Consuelo Arista Ar\u00e9valo <\/i><\/b><\/p>\n<p><b><i><\/i><\/b><strong><em>QA Specialist & Pharmacovigilance and <\/em><\/strong><strong><em>Technovigilance Coordinator<\/em><\/strong><\/p>\n<p><b><i><\/i><\/b><b><i>SCR Consultores Peru<\/i><\/b><\/p>\n<p>La tercerizaci\u00f3n de servicios de farmacovigilancia es una estrategia cada vez m\u00e1s utilizada por las empresas farmac\u00e9uticas para optimizar recursos y garantizar el cumplimiento normativo. Sin embargo, esta pr\u00e1ctica debe llevarse a cabo bajo estrictos est\u00e1ndares de calidad y regulaciones establecidas. En el <strong>Manual de Buenas Pr\u00e1cticas de Farmacovigilancia<\/strong> (Resoluci\u00f3n Ministerial N.\u00ba 1053-2020-MINSA), se establecen los lineamientos y condiciones que deben cumplir las empresas que deciden subcontratar estos servicios, con el fin de proteger la salud p\u00fablica y asegurar la calidad en la vigilancia de los productos farmac\u00e9uticos.<\/p>\n<ol>\n<li><strong> Cumplimiento Normativo<\/strong><\/li>\n<\/ol>\n<p>La empresa tercerizada debe cumplir con todas las disposiciones del <strong>Manual de Buenas Pr\u00e1cticas de Farmacovigilancia<\/strong> y la normativa nacional vigente en la materia. El incumplimiento de estos requisitos puede derivar en sanciones regulatorias y afectar la seguridad de los pacientes.<\/p>\n<ol start=\"2\">\n<li><strong> Capacidades de la Empresa Tercerizadora<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Requisitos t\u00e9cnicos:<\/strong>: La empresa contratada debe contar con experiencia comprobada en farmacovigilancia, con personal capacitado y procesos documentados para garantizar la calidad de sus servicios.<\/li>\n<li><strong>Infraestructura<\/strong>: Debe disponer de herramientas tecnol\u00f3gicas adecuadas para el monitoreo, an\u00e1lisis y reporte de eventos adversos, garantizando la integridad y confidencialidad de la informaci\u00f3n.<\/li>\n<\/ul>\n<ol start=\"3\">\n<li><strong> Responsabilidades Claras<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Contrato de Tercerizaci\u00f3n:<\/strong>Es fundamental que el contrato entre ambas partes defina con claridad las responsabilidades y obligaciones de cada una.<\/li>\n<li><strong>Supervisi\u00f3n y Control:<\/strong>La empresa contratante sigue siendo la responsable final en materia de farmacovigilancia de sus productos y debe establecer mecanismos de seguimiento y auditor\u00eda para garantizar el cumplimiento de los est\u00e1ndares establecidos.<\/li>\n<\/ul>\n<ol start=\"4\">\n<li><strong> Confidencialidad<\/strong><\/li>\n<\/ol>\n<p>The service provider must guarantee the protection of patients\u2019 personal data and the confidentiality of information related to pharmaceutical products, preventing any misuse of such data.<\/p>\n<ol start=\"5\">\n<li><strong> Auditor\u00eda y Monitoreo<\/strong><\/li>\n<\/ol>\n<p>La empresa contratante debe establecer mecanismos de auditor\u00eda y supervisi\u00f3n para evaluar peri\u00f3dicamente el desempe\u00f1o del proveedor tercerizado. Es recomendable contar con formatos de evaluaci\u00f3n para medir la calidad del servicio prestado y asegurar el cumplimiento de los requisitos regulatorios.<\/p>\n<ol start=\"6\">\n<li><strong> Entrenamiento y Capacitaci\u00f3n<\/strong><\/li>\n<\/ol>\n<p>El personal involucrado en la farmacovigilancia debe recibir capacitaci\u00f3n continua para mantenerse actualizado en normativas y mejores pr\u00e1cticas. La empresa contratante debe verificar que el proveedor tercerizado cuente con programas de formaci\u00f3n adecuados para su equipo.<\/p>\n<ol start=\"7\">\n<li><strong> Continuidad del Servicio<\/strong><\/li>\n<\/ol>\n<p>Para evitar interrupciones en la farmacovigilancia, el contrato de tercerizaci\u00f3n debe incluir planes de contingencia ante posibles fallas operativas. Adem\u00e1s, cualquier modificaci\u00f3n o transferencia de actividades a un tercero debe ser notificada al <strong>CENAFYT<\/strong> para su validaci\u00f3n y registro.<\/p>\n<p><strong>Conclusi\u00f3n<\/strong><\/p>\n<p>La tercerizaci\u00f3n de servicios de farmacovigilancia es una alternativa viable para optimizar procesos y cumplir con los requerimientos regulatorios. No obstante, debe realizarse con un enfoque estrat\u00e9gico que garantice el cumplimiento normativo, la calidad del servicio y la seguridad de los pacientes. En <strong>SCR Consulting<\/strong>brindamos asesor\u00eda especializada para garantizar que la tercerizaci\u00f3n en farmacovigilancia se lleve a cabo bajo los m\u00e1s altos est\u00e1ndares de calidad y cumplimiento regulatorio.<\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Q.F. Milagros Consuelo Arista Ar\u00e9valo QA Specialist &#038; Pharmacovigilance and Technovigilance Coordinator SCR Consulting Peru The outsourcing of pharmacovigilance services is an increasingly utilized strategy by pharmaceutical companies to optimize resources and ensure regulatory compliance. However, this practice must be conducted under strict quality standards and established regulations. The Good Pharmacovigilance Practices Manual (Ministerial Resolution [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5225,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86,82,89],"tags":[],"class_list":["post-5224","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-good-pharmacovigilance-practices","category-pharmaceutical-products","category-pharmacovigilance-analyst"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacovigilance Outsourcing in Peru: RM 1053-2020<\/title>\n<meta name=\"description\" content=\"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/scrconsultings.com\/es\/pharmacovigilance-outsourcing-peru\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacovigilance Outsourcing in Peru: RM 1053-2020\" \/>\n<meta property=\"og:description\" content=\"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/scrconsultings.com\/es\/pharmacovigilance-outsourcing-peru\/\" \/>\n<meta property=\"og:site_name\" content=\"SCR Consulting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCRConsultings\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-10T19:24:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T18:23:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"402\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"SCR Insights\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"SCR Insights\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/\"},\"author\":{\"name\":\"SCR Insights\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/person\\\/459dfaf478511fd24e1cb05282a14bbd\"},\"headline\":\"Key Considerations in the Outsourcing of Pharmacovigilance Services\",\"datePublished\":\"2025-03-10T19:24:16+00:00\",\"dateModified\":\"2026-01-27T18:23:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/\"},\"wordCount\":421,\"publisher\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_tercerizacion-Farmacovigilancia-02.png\",\"articleSection\":[\"Good Pharmacovigilance Practices\",\"Pharmaceutical products\",\"Pharmacovigilance Analyst\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/\",\"name\":\"Pharmacovigilance Outsourcing in Peru: RM 1053-2020\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_tercerizacion-Farmacovigilancia-02.png\",\"datePublished\":\"2025-03-10T19:24:16+00:00\",\"dateModified\":\"2026-01-27T18:23:56+00:00\",\"description\":\"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#primaryimage\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_tercerizacion-Farmacovigilancia-02.png\",\"contentUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_tercerizacion-Farmacovigilancia-02.png\",\"width\":1024,\"height\":402,\"caption\":\"Key Considerations in the outsourcing of pharmacovigilance services\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/pharmacovigilance-outsourcing-peru\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Key Considerations in the Outsourcing of Pharmacovigilance Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/\",\"name\":\"Scr Consultings\",\"description\":\"Specialized Consulting Firm\",\"publisher\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\",\"name\":\"Scr Consultings\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo-scr-consulting-592x236-1.png\",\"contentUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo-scr-consulting-592x236-1.png\",\"width\":592,\"height\":236,\"caption\":\"Scr Consultings\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SCRConsultings\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/scr-consultings\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCbj63X1Sg-ZnCuWY4rMC5JA\\\/videos\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/person\\\/459dfaf478511fd24e1cb05282a14bbd\",\"name\":\"SCR Insights\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"caption\":\"SCR Insights\"},\"sameAs\":[\"https:\\\/\\\/scrconsultings.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacovigilance Outsourcing in Peru: RM 1053-2020","description":"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/scrconsultings.com\/es\/pharmacovigilance-outsourcing-peru\/","og_locale":"es_ES","og_type":"article","og_title":"Pharmacovigilance Outsourcing in Peru: RM 1053-2020","og_description":"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.","og_url":"https:\/\/scrconsultings.com\/es\/pharmacovigilance-outsourcing-peru\/","og_site_name":"SCR Consulting","article_publisher":"https:\/\/www.facebook.com\/SCRConsultings","article_published_time":"2025-03-10T19:24:16+00:00","article_modified_time":"2026-01-27T18:23:56+00:00","og_image":[{"width":1024,"height":402,"url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png","type":"image\/png"}],"author":"SCR Insights","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"SCR Insights","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#article","isPartOf":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/"},"author":{"name":"SCR Insights","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/person\/459dfaf478511fd24e1cb05282a14bbd"},"headline":"Key Considerations in the Outsourcing of Pharmacovigilance Services","datePublished":"2025-03-10T19:24:16+00:00","dateModified":"2026-01-27T18:23:56+00:00","mainEntityOfPage":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/"},"wordCount":421,"publisher":{"@id":"https:\/\/scrconsultings.com\/es\/#organization"},"image":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#primaryimage"},"thumbnailUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png","articleSection":["Good Pharmacovigilance Practices","Pharmaceutical products","Pharmacovigilance Analyst"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/","url":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/","name":"Pharmacovigilance Outsourcing in Peru: RM 1053-2020","isPartOf":{"@id":"https:\/\/scrconsultings.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#primaryimage"},"image":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#primaryimage"},"thumbnailUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png","datePublished":"2025-03-10T19:24:16+00:00","dateModified":"2026-01-27T18:23:56+00:00","description":"Learn the key requirements for pharmacovigilance outsourcing in Peru under RM 1053-2020-MINSA: provider capabilities, contracts, confidentiality, audits, training and continuity plans.","breadcrumb":{"@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#primaryimage","url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png","contentUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_tercerizacion-Farmacovigilancia-02.png","width":1024,"height":402,"caption":"Key Considerations in the outsourcing of pharmacovigilance services"},{"@type":"BreadcrumbList","@id":"https:\/\/scrconsultings.com\/pharmacovigilance-outsourcing-peru\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/scrconsultings.com\/es\/"},{"@type":"ListItem","position":2,"name":"Key Considerations in the Outsourcing of Pharmacovigilance Services"}]},{"@type":"WebSite","@id":"https:\/\/scrconsultings.com\/es\/#website","url":"https:\/\/scrconsultings.com\/es\/","name":"Scr Consultings","description":"Specialized Consulting Firm","publisher":{"@id":"https:\/\/scrconsultings.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/scrconsultings.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/scrconsultings.com\/es\/#organization","name":"Scr Consultings","url":"https:\/\/scrconsultings.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2024\/07\/logo-scr-consulting-592x236-1.png","contentUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2024\/07\/logo-scr-consulting-592x236-1.png","width":592,"height":236,"caption":"Scr Consultings"},"image":{"@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCRConsultings","https:\/\/www.linkedin.com\/company\/scr-consultings\/","https:\/\/www.youtube.com\/channel\/UCbj63X1Sg-ZnCuWY4rMC5JA\/videos"]},{"@type":"Person","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/person\/459dfaf478511fd24e1cb05282a14bbd","name":"SCR Insights","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","url":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","caption":"SCR Insights"},"sameAs":["https:\/\/scrconsultings.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts\/5224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/comments?post=5224"}],"version-history":[{"count":0,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts\/5224\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/media\/5225"}],"wp:attachment":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/media?parent=5224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/categories?post=5224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/tags?post=5224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}